InflaRx Announces Initiation of its Commitment Program for G

InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization but do not survive. InflaRx is determined to support broader access to GOHIBIC for eligible...

Related Keywords

United States , Germany , Munich , Bayern , Laurie Doyle , Christian Sandrock , Regina Lutz , Nielsc Riedemann , Inflarx Gmb , Katja Arnold , Exchange Commission , Inflarx Commitment Program , Commitment Program , European Medicines Agency , Inflarx Pharmaceuticals Inc , Centers For Disease , Uc Davis Health , Mc Services , Drug Administration , Division Vice , Emergency Use Authorization , Disease Control , Division Vice Chair , Internal Medicine , Critical Care , Chief Executive Officer , Lancet Respiratory , Healthcare Facilities , Inflarx Commitment , Fact Sheet , Healthcare Providers , Safety Information , Viral Sepsis , Inflarx Pharmaceuticals , Ann Arbor , Marketing Authorization Application , Eligibility Requirements , Markets ,